Test Done Observed Value Unit Ref. Range: LDH (Lactate Dehydrogenase)
Test Done Observed Value Unit Ref. Range: LDH (Lactate Dehydrogenase)
Test Done Observed Value Unit Ref. Range: LDH (Lactate Dehydrogenase)
INTERPRETATION: LDH is most often measured to check for tissue damage. The enzyme LDH is in
many body tissues, especially the heart, liver,kidney, skeletal muscle, brain, blood cells, and lungs.
Reference Values
Males : 30-400 ng/ml | Females : 13 - 150 ng/ml
Low values are suggestive of Iron deficiency.
Ferritin is a acute phase reactant and tends to rise in acute infection. So Normal or High Values do not
necessarily suggest normal Iron stores.
This test measures the amount of ferritin in the blood. Ferritin is an iron-containing protein that is the
primary form of iron stored inside of cells.
The small quantity of ferritin that is released into the blood is a reflection of the amount of total iron
stored in the body.
In healthy people, about 70% of the iron absorbed by the body is incorporated into the hemoglobin of
red blood cells. Most of the remaining 30% is stored as ferritin or as hemosiderin, a complex of iron,
proteins, and other materials. Ferritin and hemosiderin are present primarily in the liver but also in the
bone marrow, spleen, and skeletal muscles.
High values are suggestive of Iron Overlload.
Technology: ECLIA
---------------- END OF REPORT ------------------
SPECIMEN SERUM
TROPONIN I <<0.10 ng/ml up to 0.3 ng/ml
METHOD - CLIA
INTERPRETATION
Troponin I is a chemiluminescent microplate immunoassay (CMIA) for the quantitative determination
of cardiac
troponin I. Values are used to assist in the diagnosis of myocardial infraction (MI) and in the risk
stratification of patients with
acute coronary syndromes (including unstable angina and non-ST elevation) with relative risk of
mortality, myocardial infraction,
or increased probability of ischemic events.
-----------------------------------------------------------------
All results to be interpreted in conjunction with clinical signs and symptoms and other test results
Note
1. Patient samples may contain heterophilic antibodies or mouse monoclonal antibodies that could
react in immunoassays to give a falsely elevated or depressed result.
2. Results should always be interpreted in conjunction with the patient's medical history, clinical
presentation and other findings.
3. Patients receiving Biotin therapy in high doses (>5mg/day) should not be tested for at least 8 hours
after the last dose.
4. Interleukin-6 is a nonspecific marker associated with an inflammatory response and is not
diagnostic for any specific disease or disease process.
5. Test conducted on serum.
Comments
Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of functions. IL-6 production is rapidly
induced in the course of acute inflammatory reactions associated with injury, trauma, stress, infection,
brain death, neoplasia, and other situations. Sequential measurements of IL-6 in serum or plasma of
patients admitted to the ICU (intensive care unit) showed to be useful in evaluating the severity of
SIRS (Systemic Inflammatory Response Syndrome), sepsis & septic shock and to predict the outcome
of these patients. It is also useful as an early alarm marker for the detection of neonatal sepsis. IL-6
also plays a role in chronic inflammation
e.g. Rheumatoid arthritis IL-6 values (pg/mL) observed on samples from 281 ICU patients with either
a known or suspected infection (Reference: Roche IFU).
--------------------------------------------------------------------------
Category Median Minimum Maximum
--------------------------------------------------------------------------
SIRS 62.1 <1.5 2062
Sepsis 131 6.47 3122
Severe Sepsis 346 15.2 39121
Septic shock 659 8.55 171257
--------------------------------------------------------------------------
REMARK :THIS REPORT ISSUED ON RECEIVED SAMPLE.